PHASE I CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATIONC.L. Batlevi,M.L. Palomba,J. Park,E. Mead,B. Santomasso,I. Riviere,X. Wang,B. Senechal,R. Furman,J. Yang,P. Kane,M. Hall,Y. Bernal, N. Lund,C. Diamonte,J. Pineda,E. Halton,C. Moskowitz,A. Younes,M. Sadelain,R. BrentjensHematological Oncology（2019）引用 9|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
